The proportion of patients who achieved optimal therapy within 24 h after blood culture positivity was slightly higher in the post-AXDX group (61.8%) than in the pre-AXDX group (53.2%) but did not reach statistical significance (Table 3 ).
← all excerpts
Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit.
1
—
—